John Strapp, co-founder and chairman, and Ashley Hoffman, managing director, were featured by NJBIZ for their work with the Seton Hall University Business Boot Camp.
Author: tkgadmin
Boehringer Ingelheim Payor Marketing and Sales and Agency Partner, The Kinetix Group, Win Marketing Team of the Year Gold Award at PM360 Trailblazer Awards
NEW YORK, September 26, 2019 – The Kinetix Group (TKG), a New York City-based life sciences marketing agency and care delivery consultancy, has been recognized by PM360 as the agency partner supporting Boehringer Ingelheim’s (BI’s) win as Marketing Team of the Year. The team was selected by PM360 due to the inventive strategies applied throughout its payor marketing initiatives, designed to advance care and improve clinical outcomes.
PM360 Announces NASHNET, pioneered by The Kinetix Group, as a Finalist for Its 2019 Trailblazer Award
NEW YORK, August 27, 2019 – NASHNET has been selected as a finalist in the 11th annual PM360 Trailblazer Awards within the Product/Service Launch category. NASHNET is a unique, care delivery model for the treatment of non-alcoholic fatty liver disease (NAFLD) that was founded and launched in 2018 by The Kinetix Group (TKG). TKG has been chosen alongside reputable marketing firms and industry powerhouses for this award.
The Kinetix Group (TKG) partners with the Ochsner Health Network (OHN) to present the Value Summit 2019
NEW YORK, August 15, 2019 –The Kinetix Group (TKG) is proud to partner with the Ochsner Health Network (OHN) to present the third annual Value Summit on September 19-20, 2019 in New Orleans, with support from AMGA (American Medical Group Association). Registration for the event is now open and open to healthcare professionals.
The Kinetix Group has Been Recognized by Medical Marketing & Media as a Top 100 Healthcare Agency
NEW YORK, July 18, 2019 – The Kinetix Group (TKG), a New York City-based life sciences marketing agency and care delivery consultancy, has been recognized by Medical Marketing & Media (MM&M) as a top 100 healthcare agency.
Univision Joins NASHNET in Advancing Awareness of NASH in Latino Populations
NEW YORK, June 11, 2019 – NASH Network (NASHNET), a global Centers of Excellence Network represented by leading healthcare systems in collaboration with The Kinetix Group, is committed to non-alcoholic steatohepatitis (NASH) care delivery innovation with a mission to create a standard of care for NASH, a high-volume chronic condition.
NASHNET Expands Into the European Union
NEW YORK, May 16, 2019 – NASHNET, powered by The Kinetix Group, has focused its efforts on expanding its reach to the European Union. NAFLD/NASH is an international issue, affecting nearly 1 billion people around the world.1
The Kinetix Group and Consulting at McCann Health’s Research Report on Quality Measures for Nonalcoholic Steatohepatitis (NASH) to Be Presented at ISPOR 2019
NEW YORK, March 26, 2019 – The Kinetix Group, in partnership with Consulting at McCann Health, has authored a research report that has been accepted to be exhibited as a poster presentation at ISPOR 2019 in New Orleans on May 20, 2019. The report is titled, “Which Outcome & Quality Measures Do Leading KOLs Who Treat Nonalcoholic Steatohepatitis (NASH) Recommend flor Value-Based Contracting Across Multiple Stakeholders?”, and analyzes primary and secondary research, including insights gathered from 12 US key opinion leaders (KOLs).
The Kinetix Group (TKG) partners with the Ochsner Health Network (OHN) to present the Value Summit 2018 on November 29-30 in New Orleans, LA
NEW YORK, October 30, 2018 – The Kinetix Group (TKG) is proud to partner with the Ochsner Health Network (OHN) to present the second-annual Value Summit on November 29-30, 2018 in New Orleans, with support from the American Medical Group Association (AMGA).
The Kinetix Group Partners with Rimidi to Launch a Clinical Care Partnership for the Management of Nonalcoholic Steatohepatitis (NASH)
NEW YORK, August 30, 2018 – The Kinetix Group in partnership with Rimidi, an Atlanta-based health care technology firm, announced a partnership focused on improving Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) care delivery leveraging NASHNET, a global centers of excellence network.